-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on DexCom, Raises Price Target to $105

Benzinga·10/01/2026 13:06:33
RBC Capital analyst Kendall Au maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $105.